Literature DB >> 25988401

Marrow Adipose Tissue Quantification of the Lumbar Spine by Using Dual-Energy CT and Single-Voxel (1)H MR Spectroscopy: A Feasibility Study.

Miriam A Bredella1, Scott M Daley1, Mannudeep K Kalra1, J Keenan Brown1, Karen K Miller1, Martin Torriani1.   

Abstract

PURPOSE: To test the performance of dual-energy computed tomography (CT) in the assessment of marrow adipose tissue (MAT) content of the lumbar spine by using proton (hydrogen 1 [(1)H]) magnetic resonance (MR) spectroscopy as a reference standard and to determine the influence of MAT on the assessment of bone mineral density (BMD).
MATERIALS AND METHODS: This study was institutional review board approved and complied with HIPAA guidelines. Written informed consent was obtained. Twelve obese osteopenic but otherwise healthy subjects (mean age ± standard deviation, 43 years ± 13) underwent 3-T (1)H MR spectroscopy of the L2 vertebra by using a point-resolved spatially localized spectroscopy sequence without water suppression. The L2 vertebra was scanned with dual-energy CT (80 and 140 kV) by using a dual-source multi-detector row CT scanner with a calibration phantom. Mean basis material composition relative to the phantom was estimated in the L2 vertebra. Volumetric BMD was measured with and without correction for MAT. Bland-Altman 95% limits of agreement and Pearson correlation coefficients were calculated.
RESULTS: There was excellent agreement between (1)H MR spectroscopy and dual-energy CT, with a mean difference in fat fraction of -0.02 between the techniques, with a 95% confidence interval of -0.24, 0.20. There was a strong correlation between marrow fat fraction obtained with (1)H MR spectroscopy and that obtained with dual-energy CT (r = 0.91, P < .001). The presence of MAT led to underestimation of BMD, and this bias increased with increasing MAT content (P < .001).
CONCLUSION: Dual-energy CT can be used to assess MAT content and BMD of the lumbar spine in a single examination and provides data that closely agree and correlate with (1)H MR spectroscopy data. (©) RSNA, 2015.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25988401      PMCID: PMC4613879          DOI: 10.1148/radiol.2015142876

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  24 in total

1.  Dual-energy CT-based phantomless in vivo three-dimensional bone mineral density assessment of the lumbar spine.

Authors:  Julian L Wichmann; Christian Booz; Stefan Wesarg; Konstantinos Kafchitsas; Ralf W Bauer; J Matthias Kerl; Thomas Lehnert; Thomas J Vogl; M Fawad Khan
Journal:  Radiology       Date:  2014-01-16       Impact factor: 11.105

2.  Quantitative computed tomography scanning for measurement of bone and bone marrow fat content. A comparison of single- and dual-energy techniques using a solid synthetic phantom.

Authors:  M M Goodsitt; D I Rosenthal
Journal:  Invest Radiol       Date:  1987-10       Impact factor: 6.016

3.  Potential value of vertebral proton MR spectroscopy in determining bone weakness.

Authors:  D Schellinger; C S Lin; H G Hatipoglu; D Fertikh
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

4.  Measurement of trabecular bone mineral by dual energy computed tomography.

Authors:  J E Adams; S Z Chen; P H Adams; I Isherwood
Journal:  J Comput Assist Tomogr       Date:  1982-06       Impact factor: 1.826

5.  Initial results with prereconstruction dual-energy computed tomography (PREDECT).

Authors:  W H Marshall; R E Alvarez; A Macovski
Journal:  Radiology       Date:  1981-08       Impact factor: 11.105

6.  Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT.

Authors:  Elaine W Yu; Bijoy J Thomas; J Keenan Brown; Joel S Finkelstein
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

7.  Ectopic and serum lipid levels are positively associated with bone marrow fat in obesity.

Authors:  Miriam A Bredella; Corey M Gill; Anu V Gerweck; Melissa G Landa; Vidhya Kumar; Scott M Daley; Martin Torriani; Karen K Miller
Journal:  Radiology       Date:  2013-07-16       Impact factor: 11.105

8.  Fat composition changes in bone marrow during chemotherapy and radiation therapy.

Authors:  Ruben Carmona; Jakub Pritz; Mark Bydder; Sachin Gulaya; He Zhu; Casey W Williamson; Christian S Welch; Florin Vaida; Graeme Bydder; Loren K Mell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-07-08       Impact factor: 7.038

9.  Bone marrow fat composition as a novel imaging biomarker in postmenopausal women with prevalent fragility fractures.

Authors:  Janina M Patsch; Xiaojuan Li; Thomas Baum; Samuel P Yap; Dimitrios C Karampinos; Ann V Schwartz; Thomas M Link
Journal:  J Bone Miner Res       Date:  2013-08       Impact factor: 6.741

10.  Influence of vertebral fat content on quantitative CT density.

Authors:  A M Laval-Jeantet; B Roger; S Bouysee; C Bergot; R B Mazess
Journal:  Radiology       Date:  1986-05       Impact factor: 11.105

View more
  25 in total

1.  Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission.

Authors:  C M Bastos; I M Araújo; M H Nogueira-Barbosa; C E G Salmon; F J A de Paula; L E A Troncon
Journal:  Osteoporos Int       Date:  2017-04-12       Impact factor: 4.507

2.  Bone marrow fat contributes to insulin sensitivity and adiponectin secretion in premenopausal women.

Authors:  Federica Ermetici; Silvia Briganti; Alessandra Delnevo; Paola Cannaò; Giovanni Di Leo; Stefano Benedini; Ileana Terruzzi; Francesco Sardanelli; Livio Luzi
Journal:  Endocrine       Date:  2017-06-17       Impact factor: 3.633

Review 3.  Quantitative imaging methods in osteoporosis.

Authors:  Ling Oei; Fjorda Koromani; Fernando Rivadeneira; M Carola Zillikens; Edwin H G Oei
Journal:  Quant Imaging Med Surg       Date:  2016-12

Review 4.  Bone Marrow Adiposity: Basic and Clinical Implications.

Authors:  Zachary L Sebo; Elizabeth Rendina-Ruedy; Gene P Ables; Dieter M Lindskog; Matthew S Rodeheffer; Pouneh K Fazeli; Mark C Horowitz
Journal:  Endocr Rev       Date:  2019-10-01       Impact factor: 19.871

5.  Effects of Roux-en-Y gastric bypass and sleeve gastrectomy on bone mineral density and marrow adipose tissue.

Authors:  Miriam A Bredella; Logan B Greenblatt; Alireza Eajazi; Martin Torriani; Elaine W Yu
Journal:  Bone       Date:  2016-11-15       Impact factor: 4.398

Review 6.  Marrow Adipose Tissue: Trimming the Fat.

Authors:  Erica L Scheller; William P Cawthorn; Aaron A Burr; Mark C Horowitz; Ormond A MacDougald
Journal:  Trends Endocrinol Metab       Date:  2016-04-16       Impact factor: 12.015

Review 7.  Reporting Guidelines, Review of Methodological Standards, and Challenges Toward Harmonization in Bone Marrow Adiposity Research. Report of the Methodologies Working Group of the International Bone Marrow Adiposity Society.

Authors:  Josefine Tratwal; Rossella Labella; Nathalie Bravenboer; Greet Kerckhofs; Eleni Douni; Erica L Scheller; Sammy Badr; Dimitrios C Karampinos; Sarah Beck-Cormier; Biagio Palmisano; Antonella Poloni; Maria J Moreno-Aliaga; Jackie Fretz; Matthew S Rodeheffer; Parastoo Boroumand; Clifford J Rosen; Mark C Horowitz; Bram C J van der Eerden; Annegreet G Veldhuis-Vlug; Olaia Naveiras
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-28       Impact factor: 5.555

8.  Short- and long-term reproducibility of marrow adipose tissue quantification by 1H-MR spectroscopy.

Authors:  Vibha Singhal; Karen K Miller; Martin Torriani; Miriam A Bredella
Journal:  Skeletal Radiol       Date:  2015-11-13       Impact factor: 2.199

Review 9.  Marrow adipose tissue imaging in humans.

Authors:  Vibha Singhal; Miriam A Bredella
Journal:  Bone       Date:  2018-01-10       Impact factor: 4.398

10.  Measurement of vertebral bone marrow proton density fat fraction in children using quantitative water-fat MRI.

Authors:  Stefan Ruschke; Amber Pokorney; Thomas Baum; Holger Eggers; Jeffrey H Miller; Houchun H Hu; Dimitrios C Karampinos
Journal:  MAGMA       Date:  2017-04-05       Impact factor: 2.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.